Supplementary Materials

The PDF file includes:

  • Fig. S1. Characterization of dormant tumor cells.
  • Fig. S2. Characteristics of tumor growth in vivo.
  • Fig. S3. Mechanism of dormant tumor cell reactivation.
  • Fig. S4. Characterization of cisplatin-induced tumor cell dormancy.
  • Fig. S5. Characterization of stress induction model.
  • Fig. S6. Effect of S100A9 on PMN activity.
  • Fig. S7. Characterization of lipids extracted from PMN.
  • Fig. S8. Characterization of reactivated tumor cells.
  • Table S1. Major clinical characteristics of patients with NSCLC evaluated in the study.
  • Table S2. Reagents and antibodies used in the study.
  • Table S3. Primer sequences used in this study.

[Download PDF]

Other Supplementary Material for this manuscript includes the following:

  • Data file S1 (Microsoft Excel format). Original data for Fig. 1.
  • Data file S2 (Microsoft Excel format). Original data for Fig. 2.
  • Data file S3 (Microsoft Excel format). Original data for Fig. 4.
  • Data file S4 (Microsoft Excel format). Original data for Fig. 5.
  • Data file S5 (Microsoft Excel format). Original data for Fig. 6.
  • Data file S6 (Microsoft Excel format). Original data for Fig. 7.
  • Data file S7 (Microsoft Excel format). Original data for Fig. 8.
  • Data file S8 (Microsoft Excel format). Original data for fig. S2.
  • Data file S9 (Microsoft Excel format). Original data for fig. S3.
  • Data file S10 (Microsoft Excel format). Original data for fig. S4.
  • Data file S11 (Microsoft Excel format). Original data for fig. S5.
  • Data file S12 (Microsoft Excel format). Original data for fig. S6.
  • Data file S13 (Microsoft Excel format). Original data for fig. S8.